Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-10,800
Closed -$1.24M – 13589
2026
Q1
$1.24M Buy
10,800
+5,600
+108% +$494K ﹤0.01% 7187
2025
Q4
$339K Sell
5,200
-11,300
-68% -$901K ﹤0.01% 9880
2025
Q3
$1.35M Buy
16,500
+1,400
+9% +$101K ﹤0.01% 6880
2025
Q2
$994K Sell
15,100
-37,300
-71% -$2.32M ﹤0.01% 7101
2025
Q1
$3.44M Buy
52,400
+18,200
+53% +$1.23M ﹤0.01% 4527
2024
Q4
$2.62M Buy
34,200
+3,000
+10% +$259K ﹤0.01% 5078
2024
Q3
$2.61M Buy
31,200
+10,300
+49% +$686K ﹤0.01% 5031
2024
Q2
$1.15M Buy
20,900
+7,300
+54% +$397K ﹤0.01% 6308
2024
Q1
$946K Sell
13,600
-18,900
-58% -$1.2M ﹤0.01% 7031
2023
Q4
$1.8M Buy
32,500
+28,500
+713% +$1.29M ﹤0.01% 5545
2023
Q3
$144K Sell
4,000
-2,800
-41% -$96.5K ﹤0.01% 10432
2023
Q2
$215K Buy
6,800
+2,700
+66% +$103K ﹤0.01% 9726
2023
Q1
$126K Sell
4,100
-20,400
-83% -$619K ﹤0.01% 10916
2022
Q4
$759K Buy
24,500
+5,100
+26% +$117K ﹤0.01% 7371
2022
Q3
$364K Buy
+19,400
New +$371K ﹤0.01% 9148

Other funds holding ACLX

Citadel Advisors's ACLX Position: Q2 2026 in Review

Citadel Advisors sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 21,806 shares — an estimated $2.5M sold.

Citadel Advisors first reported a position in ACLX in Q1 2022 and held it in 16 quarters. The position peaked at $97.8M in Q4 2025. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.

  • Citadel Advisors reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 21,806 Arcellx shares in Q2 2026, an estimated $2.5M.
  • Citadel Advisors first reported a position in Arcellx in Q1 2022 and held it in 16 quarters.
  • Citadel Advisors's Arcellx position peaked at $97.8M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.